× Key messages Background Summary Conclusions

Background

What do we already know about this topic?

  • Researchers have attempted to identify biomarkers in the headache field for decades.
  • The majority of research has focused on migraine with little attention paid to cluster headache.
  • The diagnostic criteria for migraine and cluster headache are distinct but biochemical levels similar.
  • As yet, no biomarkers have been established in clinical practice, but calcitonin gene-related peptide (CGRP) is currently the most promising candidate.